A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 1520-

  Langrehr, J M ^a   Klupp, J ^a   Pfitzmann, R ^a   Neumann, U ^a   Lohmann, R ^a   Jonas, S ^a   Neuhaus, R ^a   Steinmuller T ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; TACROLIMUS;

BACTERIAL INFECTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; FOLLOW UP; GRAFT REJECTION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTILYMPHOCYTE SERUM; AZATHIOPRINE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; PREDNISOLONE; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 0035077229     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02579-3     Document Type: Conference Paper

References (2)

1. European FK506 Multicentre Liver Study Group: Lancet 344:423, 1994
2. The US Multicenter FK506 Liver Study Group: N Engl J Med 331:1110, 1994